ADVFN Logo ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Dati di Mercato
Notizie
Utensili
Mercato
Scoprire

Caratteristiche principali

Follow Feed

Connettiti con trader e investitori nella nostra comunità Follow Feed.

Flusso di Opzioni

Esplora i dati completi sulle opzioni e utilizza filtri avanzati con Options Flow.

Monitor

Organizza e monitora la tua watchlist di azioni e attività con Monitor.
Accedi/Registrati Premium IconPremium Help Menu
Ftse Mib
39.212,11
-1,26%
DAX
23.005,24
-1,27%
S&P 500
5.683,21
0,14%
NASDAQ
17.811,97
0,34%
Bitcoin
84.508,98
-2,75%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati
  1. Home
  2. Investire
  3. Azioni
  4. U.S.A.
  5. NASDAQ
  6. Phio Pharmaceuticals Corporation (PHIO)

  7. Phio Pharmaceuticals Corporation (PHIO) Notizie

PHIO

Phio Pharmaceuticals (PHIO)

Phio Pharmaceuticals Corporation
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PHIO
DataOraFonteTitoloSimboloCompagnia
04/03/202522:58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PHIOPhio Pharmaceuticals Corporation
20/02/202521:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHIOPhio Pharmaceuticals Corporation
07/02/202522:09Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PHIOPhio Pharmaceuticals Corporation
29/01/202522:02Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PHIOPhio Pharmaceuticals Corporation
29/01/202506:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PHIOPhio Pharmaceuticals Corporation
28/01/202522:16Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PHIOPhio Pharmaceuticals Corporation
23/01/202521:45Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PHIOPhio Pharmaceuticals Corporation
21/01/202522:39Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PHIOPhio Pharmaceuticals Corporation
17/01/202514:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PHIOPhio Pharmaceuticals Corporation
14/11/202422:49Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PHIOPhio Pharmaceuticals Corporation
13/11/202417:20Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PHIOPhio Pharmaceuticals Corporation
13/09/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PHIOPhio Pharmaceuticals Corporation
20/05/202423:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PHIOPhio Pharmaceuticals Corporation
20/05/202422:59Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:PHIOPhio Pharmaceuticals Corporation
17/05/202415:00GlobeNewswire Inc.Phio Pharmaceuticals Secures New InvestorNASDAQ:PHIOPhio Pharmaceuticals Corporation
16/05/202414:00GlobeNewswire Inc.Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)NASDAQ:PHIOPhio Pharmaceuticals Corporation
15/05/202419:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation StudyNASDAQ:PHIOPhio Pharmaceuticals Corporation
09/05/202423:25GlobeNewswire Inc.Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business UpdateNASDAQ:PHIOPhio Pharmaceuticals Corporation
08/05/202423:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PHIOPhio Pharmaceuticals Corporation
08/05/202423:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PHIOPhio Pharmaceuticals Corporation
08/05/202423:00Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PHIOPhio Pharmaceuticals Corporation
30/04/202413:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)NASDAQ:PHIOPhio Pharmaceuticals Corporation
22/04/202419:10GlobeNewswire Inc.Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsNASDAQ:PHIOPhio Pharmaceuticals Corporation
16/04/202413:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)NASDAQ:PHIOPhio Pharmaceuticals Corporation
11/04/202413:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)NASDAQ:PHIOPhio Pharmaceuticals Corporation
03/04/202413:30GlobeNewswire Inc.National Spotlight Features Phio’s Innovative RNAi Technology PlatformNASDAQ:PHIOPhio Pharmaceuticals Corporation
02/04/202413:30GlobeNewswire Inc.Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business UpdateNASDAQ:PHIOPhio Pharmaceuticals Corporation
21/03/202412:30GlobeNewswire Inc.Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological MalignanciesNASDAQ:PHIOPhio Pharmaceuticals Corporation
13/03/202419:00GlobeNewswire Inc.Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity ResearchNASDAQ:PHIOPhio Pharmaceuticals Corporation
06/03/202416:30GlobeNewswire Inc.Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin DisordersNASDAQ:PHIOPhio Pharmaceuticals Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PHIO

La tua Cronologia

NYSE
WLKP
Westlake Chemical Partners
NASDAQ
ACTU
Actuate Therapeutics
AMEX
FTEC
Fidelity MSCI Informatio...
NASDAQ
WDC
Western Digital
GATE
CIRUSDT
CircleSwap Governance Token
NYSE
ARIS
Aris Water Solutions
AMEX
YANG
Direxion Daily FTSE Chin...
NASDAQ
CAR
Avis Budget
COIN
IRBBTC
IRobot
NYSE
SGHC
Super Group SGHC
NASDAQ
SFM
Sprouts Farmers Market
BOV
R2HH34
HR
NASDAQ
AENT
Alliance Entertainment
BOV
VLYB34
Valley National Bancorp
NASDAQI
NCX
Nasdaq Innovators Comple...
USOTC
CHKMF
Altair Minerals (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Italia
Azienda
Attività
Popular
Ottieni l'app
App Store
Google Play

Assistenza: help@advfn.com

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

© 2025 ADVFN PLC - Tutti i diritti riservati

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci